Clinical Aspects of Neurobehavioral Symptoms of Dementia
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Neurobehavioral symptoms of dementia (NBSD) are very common and are significant symptoms of the illness, contributing most to caregiver burdens and often resulting in premature institutionalization of the person with dementia. The main symptoms of NBSD are anxiety, depression, delusions, and hallucinations. NBSD produce significant problems for both patients and caregivers. The pathophysiology of NBSD is determined by genetic, structural, or environmental factors. Therefore, treatment of NBSD requires continuous and organic cooperation between patients, caregivers, social environments, and doctors. Therefore, it is important for neurologists, who mainly view NBSD for dementia patients, to increase their understanding of these more comprehensive areas as well as the latest insights and treatments to help patients and caregivers.
Abstract
Neurobehavioral symptoms of dementia (NBSD) are very common and are significant symptoms of the illness, contributing most to caregiver burdens and often resulting in premature institutionalization of the person with dementia. The main symptoms of NBSD are anxiety, depression, delusions, and hallucinations. NBSD produce significant problems for both patients and caregivers. The pathophysiology of NBSD is determined by genetic, structural, or environmental factors. Therefore, treatment of NBSD requires continuous and organic cooperation between patients, caregivers, social environments, and doctors. Therefore, it is important for neurologists, who mainly view NBSD for dementia patients, to increase their understanding of these more comprehensive areas as well as the latest insights and treatments to help patients and caregivers.
참고문헌 (55)
- Steinberg M, "Point and 5-year period prevalence of neuropsychiatric symptoms in dementia : the Cache County Study", Int J Geriatr Psychiatry, 23, pp.170~177 (2008)
- Wiener PK, "A short-term inpatient program for agitated demented nursing home residents", Int J Geriatr Psychiatry, 16, pp.866~872 (2001)
- Lyketsos CG, "Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment : results from the cardiovascular health study", JAMA, 288, pp.1475~1483 (2002)
- Leber P., "Guidelines for the Clinical Evaluation of antiDementia Drugs (1990 draft)", U.S. Food and Drug Administration, ~ (1990)
- 곽용태, "Clinical Characteristics of Behavioral and Psychological Symptoms in Patients with Drug-naïve Alzheimer’s Disease", Dementia and Neurocognitive Disorders(대한치매학회지), 11(3), pp.87~94 (2012), 대한치매학회
- Bjoerke-Bertheussen J, "Neuropsychiatric symptoms in mild dementia with Lewy bodies and Alzheimer's disease", Dement Geriatr Cogn Disord, 34, pp.1~6 (2012)
- Fernández-Martínez M, "Prevalence of neuropsychiatric symptoms in Alzheimer's disease and vascular dementia", Curr Alzheimer Res, 5, pp.61~69 (2008)
- Warren JD, "Clinical review. Frontotemporal dementia", BMJ, 347, pp.f4827~ (2013)
- Prado-Jean A, "Specific psychological and behavioral symptoms of depression in patients with dementia", Int J Geriatr Psychiatry, 25, pp.1065~1072 (2010)
- Kwak YT, "Clinical characteristics according to depression screening tools in patients with Alzheimer's disease : view from self, caregiver-reported and drug-intervention pattern", Geriatr Gerontol Int, 14, pp.660~666 (2014)
- Zubenko GS, "A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease", Am J Psychiatry, 160, pp.857~866 (2003)
- Robert P, "Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders", Eur Psychiatry, 24, pp.98~104 (2009)
- Mulin E, "Diagnostic criteria for apathy in clinical practice", Int J Geriatr Psychiatry, 26, pp.158~165 (2011)
- Kwak YT, "Delusions of Korean patients with Alzheimer's disease : study of drug-naïve patients", Geriatr Gerontol Int, 13, pp.307~313 (2013)
- Schneider K, "Clinical Psychopathology" (1959), Grune & Stratton
- Harciarek M, "The prevalence of misidentification syndromes in neurodegenerative diseases", Alzheimer Dis Assoc Disord, 22, pp.163~169 (2008)
- Perini G, "Misidentification delusions : prevalence in different types of dementia and validation of a structured questionnaire", Alzheimer Dis Assoc Disord, 30, pp.331~337 (2016)
- Sharp SI, "Aggressive behavior and neuroleptic medication are associated with increased number of alpha1-adrenoceptors in patients with Alzheimer disease", Am J Geriatr Psychiatry, 15, pp.435~437 (2007)
- Jeste DV, "Cognitive deficits of patients with Alzheimer's disease with and without delusions", Am J Psychiatry, 149, pp.184~189 (1992)
- Murayama N, "Risk factors for delusion of theft in patients with Alzheimer's disease showing mild dementia in Japan", Aging Ment Health, 13, pp.563~568 (2009)
- Jeste DV, "Conventional vs. newer antipsychotics in elderly patients", Am J Geriatr Psychiatry, 7, pp.70~76 (1999)
- McKeith IG, "Diagnosis and management of dementia with Lewy bodies : third report of the DLB Consortium", Neurology, 65, pp.1863~1872 (2005)
- Hope T, "Natural history of behavioural changes and psychiatric symptoms in Alzheimer's disease. A longitudinal study", Br J Psychiatry, 174, pp.39~44 (1999)
- 곽용태, "Wandering in Dementia", Dementia and Neurocognitive Disorders(대한치매학회지), 14(3), pp.99~105 (2015), 대한치매학회[DOI]
- Cohen-Mansfield J, "Can agitated behavior of nursing home residents with dementia be prevented with the use of standardized stimuli", J Am Geriatr Soc, 58, pp.1459~1464 (2010)
- Mishima K, "Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer's type with disturbed sleep-waking", Biol Psychiatry, 45, pp.417~421 (1999)
- Rongve A, "Frequency and correlates of caregiver-reported sleep disturbances in a sample of persons with early dementia", J Am Geriatr Soc, 58, pp.480~486 (2010)
- Cipriani G, "Eating behaviors and dietary changes in patients with dementia", Am J Alzheimers Dis Other Demen, 31, pp.706~716 (2016)
- Reisberg B, "Behavioral symptoms in Alzheimer's disease : phenomenology and treatment", J Clin Psychiatry, 48(Suppl), pp.9~15 (1987)
- Cummings JL, "The Neuropsychiatric Inventory : assessing psychopathology in dementia patients", Neurology, 48, pp.S10~S16 (1997)
- Robert PH, "Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium", Eur Psychiatry, 20, pp.490~496 (2005)
- Aalten P, "Behavioral problems in dementia : a factor analysis of the neuropsychiatric inventory", Dement Geriatr Cogn Disord, 15, pp.99~105 (2003)
- Spalletta G, "Neuropsychiatric symptoms and syndromes in a large cohort of newly diagnosed, untreated patients with Alzheimer disease", Am J Geriatr Psychiatry, 18, pp.1026~1035 (2010)
- Scarmeas N, "Association between the APOE genotype and psychopathologic symptoms in Alzheimer's disease", Neurology, 58, pp.1182~1188 (2002)
- Craig D, "Association analysis of apolipoprotein E genotype and risk of depressive symptoms in Alzheimer's disease", Dement Geriatr Cogn Disord, 19, pp.154~157 (2005)
- Go RC, "Neuregulin-1 polymorphism in late onset Alzheimer's disease families with psychoses", Am J Med Genet B Neuropsychiatr Genet, 139, pp.28~32 (2005)
- Sweet RA, "Catechol-O-methyltransferase haplotypes are associated with psychosis in Alzheimer disease", Mol Psychiatry, 10, pp.1026~1036 (2005)
- Craig D, "The interleukin 1β gene promoter polymorphism(-511)acts as a risk factor for psychosis in Alzheimer's dementia", Ann Neurol, 56, pp.121~124 (2004)
- Sato N, "Dopamine D3 receptor gene polymorphism influences on behavioral and psychological symptoms of dementia(BPSD)in mild dementia of Alzheimer's type", J Alzheimers Dis, 17, pp.441~448 (2009)
- Ramanathan S, "Serotonergic system genes in psychosis of Alzheimer dementia : meta-analysis", Am J Geriatr Psychiatry, 17, pp.839~846 (2009)
- Middle F, "No association between neuregulin 1 and psychotic symptoms in Alzheimer's disease patients", J Alzheimers Dis, 20, pp.561~567 (2010)
- Marra C, "Central cholinergic dysfunction measured"in vivo"correlates with different behavioral disorders in Alzheimer's disease and dementia with Lewy body", Brain Stimulat, 5, pp.533~538 (2012)
- Minger SL, "Cholinergic deficits contribute to behavioral disturbance in patients with dementia", Neurology, 55, pp.1460~1467 (2000)
- Zubenko GS, "Neuropathologic and neurochemical correlates of psychosis in primary dementia", Arch Neurol, 48, pp.619~624 (1991)
- Assal F, "Association of the serotonin transporter and receptor gene polymorphisms in neuropsychiatric symptoms in Alzheimer disease", Arch Neurol, 61, pp.1249~1253 (2004)
- Förstl H, "Neuropathological correlates of behavioural disturbance in confirmed Alzheimer's disease", Br J Psychiatry, 163, pp.364~368 (1993)
- Farber NB, "Increased neocortical neurofibrillary tangle density in subjects with Alzheimer disease and psychosis", Arch Gen Psychiatry, 57, pp.1165~1173 (2000)
- Hargrave R, "Affective behavioural disturbances in Alzheimer's disease and ischaemic vascular disease", J Neurol Neurosurg Psychiatry, 68, pp.41~46 (2000)
- Hirono N, "Frontal lobe hypometabolism and depression in Alzheimer's disease", Neurology, 50, pp.380~383 (1998)
- Holthoff VA, "Regional cerebral metabolism in early Alzheimer's disease with clinically significant apathy or depression", Biol Psychiatry, 57, pp.412~421 (2005)
- Meeks TW, "The neurobiology of neuropsychiatric syndromes in dementia", Curr Opin Psychiatry, 19, pp.581~586 (2006)
- Koppel J, "Psychosis in Alzheimer's disease is associated with frontal metabolic impairment and accelerated decline in working memory : findings from the Alzheimer's Disease Neuroimaging Initiative", Am J Geriatr Psychiatry, 22, pp.698~707 (2014)
- Eslinger PJ, "Apathy in frontotemporal dementia : behavioral and neuroimaging correlates", Behav Neurol, 25, pp.127~136 (2012)
- Selbaek G, "The course of neuropsychiatric symptoms in nursing-home patients with dementia over a 53-month follow-up period", Int Psychogeriatr, 26, pp.81~91 (2014)
- Tschanz JT, "Progression of cognitive, functional, and neuropsychiatric symptom domains in a population cohort with Alzheimer dementia : the Cache County Dementia Progression study", Am J Geriatr Psychiatry, 19, pp.532~542 (2011)
